Last update: May 9, 2026 at 09:32
Dividend Safety Rating
ABBV's dividend shows some areas that warrant monitoring. Strengths include a 53.2% fcf payout ratio & 31.6% operating margin. Areas of concern: 326.0% earnings payout ratio & 0.7x current ratio. As a Dividend Aristocrat with 25+ consecutive years of increases, ABBV has a proven commitment to shareholders.
Based on 15 of 15 metrics
Strengths
- Operating Margin: 31.6%Healthy operating margin provides a wide buffer.
- Gross Margin: 72.6%High gross margin signals strong pricing power.
- Dividend Streak: Aristocrat (25+ yrs)Long, uninterrupted dividend track record.
Risks
- Earnings Payout Ratio: 326.0%High earnings payout ratio leaves little safety margin.
- Current Ratio: 0.7xLimited short-term liquidity to meet obligations.
- Debt-to-Equity: -21.2Debt-to-equity is elevated for the sector.
Payout & Coverage
CautionBalance Sheet
WarningProfitability
CautionDividend Track Record
Very SafeAbout AbbVie Inc.
AbbVie Inc. is a research-based biopharmaceutical company focused on the discovery, development, manufacturing, and commercialization of innovative medicines and therapies worldwide. Headquartered in North Chicago, Illinois, and founded in 2012 as a spin-off from Abbott Laboratories, it employs approximately 55,000 people and operates primarily in the pharmaceuticals and biotechnology sector. Key products include Humira, a leading treatment for autoimmune diseases such as rheumatoid arthritis, Crohn's disease, and psoriasis; Skyrizi and Rinvoq for immunology indications like plaque psoriasis and ulcerative colitis; Imbruvica for blood cancers; and Botox for neurological conditions and aesthetics following the 2020 Allergan acquisition. AbbVie Inc. maintains a robust pipeline addressing immunology, oncology, neuroscience, and other therapeutic areas, with recent advancements in treatments for essential tremor and kidney disease. Its global presence underscores its significant role in advancing healthcare solutions and contributing to the biopharmaceutical industry's growth.
Dividend Overview
Dividend Yield
3.35%
Annual Dividend
$6.74
Frequency
Quarterly
Payout Ratio
325.98%
FCF Payout Ratio
53.19%
Stock Price
$201.55
52-Week Range
$176.57 – $244.81
Dividend History (2016–2025)
ABBV annual dividend per share and yield history
Earnings & Profitability
ABBV earnings per share and net profit margin
Key Dates
Last Ex-Dividend Date
April 15, 2026
Next Payment Date
May 15, 2026
Dividend Growth
3-Year Dividend CAGR
5.17%
5-Year Dividend CAGR
6.81%
10-Year Dividend CAGR
12.50%
3-Year Total Growth
16.31%
5-Year Total Growth
38.98%
10-Year Total Growth
224.75%
Dividend Aristocrat (25+ yrs)
This company has increased its dividend for 25+ consecutive years.
Income Calculator
Similar Dividend Stocks
Frequently Asked Questions
What is ABBV's current dividend yield?
When is ABBV's next dividend payment date?
How much does ABBV pay in dividends per year?
Has ABBV been increasing its dividend?
Is ABBV's dividend safe?
How is ABBV's Dividend Safety Rating calculated?
Want to understand how we rate dividend safety? Read our full methodology
Track ABBV Dividends with OnlyDividends
What will ABBV actually pay you after taxes? Track every payout, get notified on payment dates, and stop guessing.
This page is not investment advice. The content is for informational purposes only and should not be construed as a recommendation to buy, sell, or hold any security. Always do your own research and consult a qualified financial advisor before making investment decisions.
Financial data, including dividend history, earnings, balance sheet metrics, and the Dividend Safety Rating, is provided for informational purposes only. Data may be delayed or differ from official filings. Past performance does not guarantee future results. Always verify with official sources before making investment decisions.
Market data provided by Twelve Data.